These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 20085229)
61. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Morand K; Bartoletti AC; Bochot A; Barratt G; Brandely ML; Chast F Int J Pharm; 2007 Nov; 344(1-2):150-3. PubMed ID: 17669608 [TBL] [Abstract][Full Text] [Related]
62. Evaluation of preservative systems in opthalmic suspension of polymyxin B and dexamethasone by linear regression. Bou-Chacra NA; Pinto TJ; Kaneko TM Pharmazie; 2007 Mar; 62(3):199-204. PubMed ID: 17416196 [TBL] [Abstract][Full Text] [Related]
64. [Incidence of hypersensitivity to antibiotics and preservatives in eye drops]. Rudzki E; Kecik T; Portacha L; Rebandel P; Pauk M Klin Oczna; 1995; 97(3-4):66-7. PubMed ID: 7474796 [TBL] [Abstract][Full Text] [Related]
65. [Low-level challenge test for the examination of the microbiological susceptibility, during the period of use, of liquid and semi-solid dosage forms in multiple-dose containers (author's transl)]. Urban S; Hecker W; Schiller I Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 172(6):478-84. PubMed ID: 7257652 [TBL] [Abstract][Full Text] [Related]
66. Stability of latanoprost in an ophthalmic lipid emulsion using polyvinyl alcohol. Sakai Y; Yasueda S; Ohtori A Int J Pharm; 2005 Nov; 305(1-2):176-9. PubMed ID: 16207517 [TBL] [Abstract][Full Text] [Related]
67. [Pharmaceutical investigation of vancomycin hydrochloride eye drops and their topical application to MRSA eye infection]. Itoh M; Aoyama T; Iemoto A; Nakajima K; Amano S; Nakamura H; Sato H; Iga T Yakugaku Zasshi; 2001 Jun; 121(6):433-9. PubMed ID: 11433777 [TBL] [Abstract][Full Text] [Related]
68. Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization. Novack GD; Evans R J Glaucoma; 2001 Dec; 10(6):483-6. PubMed ID: 11740219 [TBL] [Abstract][Full Text] [Related]
69. Non-preserved 1% lidocaine solution has less antibacterial properties than currently available anaesthetic eye-drops. Labetoulle M; Frau E; Offret H; Nordmann P; Naas T Curr Eye Res; 2002 Aug; 25(2):91-7. PubMed ID: 12525962 [TBL] [Abstract][Full Text] [Related]
70. Antimicrobial Effectiveness in Eye Drops: Limited Sterility versus Reduction in Microbial Count. Abu Shaqra QM; Al-Groom RM; Abu Shaqra AQ PDA J Pharm Sci Technol; 2020; 74(3):309-317. PubMed ID: 31941794 [TBL] [Abstract][Full Text] [Related]
71. Stability and in vitro toxicity of an infliximab eye drop formulation. Robert MC; Spurr-Michaud S; Frenette M; Young D; Gipson IK; Dohlman CH Int J Pharm Compd; 2014; 18(5):418-26. PubMed ID: 25577892 [TBL] [Abstract][Full Text] [Related]
72. Stability studies of five anti-infectious eye drops under exhaustive storage conditions. Curti C; Lamy E; Primas N; Fersing C; Jean C; Bertault-Peres P; Vanelle P Pharmazie; 2017 Dec; 72(12):741-746. PubMed ID: 29441959 [TBL] [Abstract][Full Text] [Related]
73. Stability of tacrolimus ophthalmic solution. Ezquer-Garin C; Ferriols-Lisart R; Alós-Almiñana M Am J Health Syst Pharm; 2017 Jul; 74(13):1002-1006. PubMed ID: 28645998 [TBL] [Abstract][Full Text] [Related]
75. Stability of extemporaneously prepared voriconazole ophthalmic solution. Al-Badriyeh D; Li J; Stewart K; Kong DC; Leung L; Davies GE; Fullinfaw R Am J Health Syst Pharm; 2009 Aug; 66(16):1478-83. PubMed ID: 19667005 [TBL] [Abstract][Full Text] [Related]
76. The decomposition of phenylmercuric nitrate caused by disodium edetate in neomycin eye drops during the process of heat sterilization. Parkin JE; Button KL; Maroudas PA J Clin Pharm Ther; 1992 Jun; 17(3):191-6. PubMed ID: 1639882 [TBL] [Abstract][Full Text] [Related]
77. Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension. Lambert O; Bandilla D Drug Des Devel Ther; 2012; 6():235-44. PubMed ID: 23049244 [TBL] [Abstract][Full Text] [Related]
78. Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers. Roche M; Lannoy D; Bourdon F; Danel C; Labalette P; Berneron C; Simon N; Odou P Eur J Pharm Sci; 2020 Jan; 141():105102. PubMed ID: 31655210 [TBL] [Abstract][Full Text] [Related]
79. Stability of freeze-dried plasma rich in growth factors eye drops stored for 3 months at different temperature conditions. Anitua E; de la Fuente M; Muruzábal F; Merayo-Lloves J Eur J Ophthalmol; 2021 Mar; 31(2):354-360. PubMed ID: 32178524 [TBL] [Abstract][Full Text] [Related]
80. The effect of low density polyethylene containers on some hospital-manufactured eyedrop formulations. II. Inhibition of the sorption of phenylmercuric acetate. Aspinall JE; Duffy TD; Taylor CG J Clin Hosp Pharm; 1983 Sep; 8(3):233-40. PubMed ID: 6630562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]